Posterior Fossa Horns in Hurler Syndrome: Prevalence and Regression

References

1. 1.↵
   1. Muenzer J

   . Overview of the mucopolysaccharidoses. Rheumatology (Oxford) 2011;50(Suppl 5):v4–v12 doi:10.1093/rheumatology/ker394 pmid:22210669

   CrossRefPubMed
2. 2.↵
   1. Muenzer J,
   2. Wraith JE,
   3. Clarke LA

   ; International Consensus Panel on Management and Treatment of Mucopolysaccharidosis I. Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 2009;123:19–29 doi:10.1542/peds.2008-0416 pmid:19117856

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Dusing SC

   . Developmental outcomes in children with Hurler syndrome after stem cell transplantation. Dev Med Child Neurol 2007;49:646 doi:10.1111/j.1469-8749.2007.00646.x pmid:17718818

   CrossRefPubMed
4. 4.↵
   1. Eisengart JB,
   2. Rudser KD,
   3. Tolar J, et al

   . Enzyme replacement is associated with better cognitive outcomes after transplant in Hurler syndrome. J Pediatr 2013;162:375–80.e1 doi:10.1016/j.jpeds.2012.07.052 pmid:22974573

   CrossRefPubMed
5. 5.↵
   1. Hampe CS,
   2. Wesley J,
   3. Lund TC, et al

   . Mucopolysaccharidosis type I: current treatments, limitations, and prospects for improvement. Biomolecules 2021;11:189 doi:10.3390/biom11020189 pmid:33572941

   CrossRefPubMed
6. 6.↵
   1. Eisengart JB,
   2. Rudser KD,
   3. Xue Y, et al

   . Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison. Genet Med 2018;20:1423–29 doi:10.1038/gim.2018.29 pmid:29517765

   CrossRefPubMed
7. 7.↵
   1. Matheus MG,
   2. Castillo M,
   3. Smith JK, et al

   . Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 2004;46:666–72 doi:10.1007/s00234-004-1215-1 pmid:15205860

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Palmucci S,
   2. Attinà G,
   3. Lanza ML, et al

   . Imaging findings of mucopolysaccharidoses: a pictorial review. Insights Imaging 2013;4:443–59 doi:10.1007/s13244-013-0246-8 pmid:23645566

   CrossRefPubMed
9. 9.↵
   1. Damar Ç,
   2. Derinkuyu BE,
   3. Kiliçkaya MA, et al

   . Posterior fossa horns; a new calvarial finding of mucopolysaccharidoses with well-known cranial MRI features. Turk J Med Sci 2020;50:1048–61 doi:10.3906/sag-1908-70 pmid:32011835

   CrossRefPubMed
10. 10.↵
    1. White KK,
    2. Sousa T

    . Mucopolysaccharide disorders in orthopaedic surgery. J Am Acad Orthop Surg 2013;21:12–22 doi:10.5435/JAAOS-21-01-12 pmid:23281467

    CrossRefPubMed
11. 11.↵
    1. Oussoren E,
    2. Mathijssen IM,
    3. Wagenmakers M, et al

    . Craniosynostosis affects the majority of mucopolysaccharidosis patients and can contribute to increased intracranial pressure. J Inherit Metab Dis 2018;41:1247–58 doi:10.1007/s10545-018-0212-1 pmid:30083803

    CrossRefPubMed
12. 12.↵
    1. Opperman LA

    . Cranial sutures as intramembranous bone growth sites. Dev Dyn 2000;219:472–85 doi:10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F pmid:11084647

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Vu GH,
    2. Xu W,
    3. Go BC, et al

    . Physiologic timeline of cranial-base suture and synchondrosis closure. Plast Reconstr Surg 2021;148:973E–82E doi:10.1097/PRS.0000000000008570 pmid:34705810

    CrossRefPubMed
14. 14.↵
    1. Rodriguez JJ,
    2. Mclaughlin ÃC,
    3. Thompson JT

    . Analysis of cranial base suture fusion patterns. J Craniofac Surg 2021;32:1679–82 doi:10.1097/SCS.0000000000007246 pmid:33229996

    CrossRefPubMed